# CAR-T Long Term Follow Up (LTFU) Study

> **NCT02445222** · PHASE3 · RECRUITING · sponsor: **Novartis Pharmaceuticals** · enrollment: 1400 (estimated)

## Conditions studied

- Long Term Safety of Patients Receiving CAR-T in an Eligible Clinical Trial or Managed Access Program

## Interventions

- **GENETIC:** Previously treated CAR-T patients

## Key facts

- **NCT ID:** NCT02445222
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2015-11-02
- **Primary completion:** 2036-02-22
- **Final completion:** 2036-02-22
- **Target enrollment:** 1400 (ESTIMATED)
- **Last updated:** 2025-10-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02445222

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02445222, "CAR-T Long Term Follow Up (LTFU) Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02445222. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*